DCF Tool


analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.
Analysis Results
Intrinsic Value $98.16
Latest Price $140.73
Relative Value 43% overvalued
Thoughts on this result? Let us know.
Cash Flow (Billions)
Analysis Parameters
New Ticker
Analysis Details
Growth Rate Projection

An exponential growth model was fit to the past cash flow data, giving more weight to more recent years. This model determined a growth rate estimate of 8.1%.

Weighted Average Cost of Capital (WACC)

The calculated WACC is 8.1%. This value is used as the default discount rate.

Value of Future Flows

Assuming a growth rate of 8.1%, the cash flows for the next 5 years are projected.

The present value of each year's flow is adjusted to present value using the discount rate.

Year Future flow (billion) Present value (billion)
2024 1.51 1.4
2025 1.63 1.4
2026 1.76 1.4
2027 1.91 1.4
2028 2.06 1.4
Terminal Value

Assuming a growth rate after the projection years of 2.0%, the terminal value of the company would be 34.7 billion. This corresponds to a present value of 21.8 billion.

Intrinsic Value Per Share

The total present value of the projected cash flows is 6.99 billion. Adding in the terminal value gives a total present value of 28.8 billion.

There are presently 293.0 million outstanding shares, so the intrinsic value per share is 98.16.

Financial Statements

The following data was to determine the past cash flows.

Current Assets 4,186,000,000
Current Cash 1,590,000,000
Current Liabilities 1,603,000,000
Current Debt 0
Non-Cash Working Capital (NCWC) 993,000,000
Change in NCWC 93,000,000
EBIT 1,350,000,000
Tax Provision 99,000,000
Depreciation and Amortization 271,000,000
Capital Expenditure -298,000,000
Unlevered Free Cash Flow 1,316,186,706
Current Assets 3,778,000,000
Current Cash 1,053,000,000
Current Liabilities 1,861,000,000
Current Debt 36,000,000
Non-Cash Working Capital (NCWC) 900,000,000
Change in NCWC 384,000,000
EBIT 1,618,000,000
Tax Provision 250,000,000
Depreciation and Amortization 317,000,000
Capital Expenditure -291,000,000
Unlevered Free Cash Flow 1,759,050,531
Current Assets 3,799,000,000
Current Cash 1,575,000,000
Current Liabilities 1,708,000,000
Current Debt 0
Non-Cash Working Capital (NCWC) 516,000,000
Change in NCWC -66,000,000
EBIT 1,347,000,000
Tax Provision 150,000,000
Depreciation and Amortization 321,000,000
Capital Expenditure -189,000,000
Unlevered Free Cash Flow 1,264,433,823
Current Assets 3,415,000,000
Current Cash 1,441,000,000
Current Liabilities 1,467,000,000
Current Debt 75,000,000
Non-Cash Working Capital (NCWC) 582,000,000
Change in NCWC 239,000,000
EBIT 846,000,000
Tax Provision 123,000,000
Depreciation and Amortization 308,000,000
Capital Expenditure -119,000,000
Unlevered Free Cash Flow 1,150,415,676
Current Assets 3,189,000,000
Current Cash 1,382,000,000
Current Liabilities 2,080,000,000
Current Debt 616,000,000
Non-Cash Working Capital (NCWC) 343,000,000
Change in NCWC -87,000,000
EBIT 941,000,000
Tax Provision -152,000,000
Depreciation and Amortization 238,000,000
Capital Expenditure -155,000,000
Unlevered Free Cash Flow 937,000,000
Current Assets 3,848,000,000
Current Cash 2,247,000,000
Current Liabilities 1,171,000,000
Current Debt 0
Non-Cash Working Capital (NCWC) 430,000,000
Change in NCWC -8,000,000
EBIT 928,000,000
Tax Provision 630,000,000
Depreciation and Amortization 210,000,000
Capital Expenditure -177,000,000
Unlevered Free Cash Flow 334,987,315
Current Assets 4,169,000,000
Current Cash 2,678,000,000
Current Liabilities 1,263,000,000
Current Debt 210,000,000
Non-Cash Working Capital (NCWC) 438,000,000
Change in NCWC 37,000,000
EBIT 841,000,000
Tax Provision 119,000,000
Depreciation and Amortization 212,000,000
Capital Expenditure -176,000,000
Unlevered Free Cash Flow 789,368,617
Current Assets 3,635,000,000
Current Cash 2,289,000,000
Current Liabilities 945,000,000
Current Debt 0
Non-Cash Working Capital (NCWC) 401,000,000
Change in NCWC -306,000,000
EBIT 615,000,000
Tax Provision 82,000,000
Depreciation and Amortization 246,000,000
Capital Expenditure -139,000,000
Unlevered Free Cash Flow 323,297,794
Current Assets 3,686,000,000
Current Cash 2,003,000,000
Current Liabilities 976,000,000
Current Debt 0
Non-Cash Working Capital (NCWC) 707,000,000
Change in NCWC -63,000,000
EBIT 513,000,000
Tax Provision 42,000,000
Depreciation and Amortization 253,000,000
Capital Expenditure -98,000,000
Unlevered Free Cash Flow 560,112,500
Current Assets 5,500,000,000
Current Cash 3,028,000,000
Current Liabilities 1,702,000,000
Current Debt 0
Non-Cash Working Capital (NCWC) 770,000,000
Change in NCWC 64,000,000
EBIT 824,000,000
Tax Provision 142,000,000
Depreciation and Amortization 384,000,000
Capital Expenditure -205,000,000
Unlevered Free Cash Flow 885,873,065
Current Assets 4,983,000,000
Current Cash 2,675,000,000
Current Liabilities 1,602,000,000
Current Debt 0
Non-Cash Working Capital (NCWC) 706,000,000
Change in NCWC 82,000,000
EBIT 953,000,000
Tax Provision 135,000,000
Depreciation and Amortization 372,000,000
Capital Expenditure -195,000,000
Unlevered Free Cash Flow 1,062,227,008
Current Assets 4,629,000,000
Current Cash 2,362,000,000
Current Liabilities 1,893,000,000
Current Debt 250,000,000
Non-Cash Working Capital (NCWC) 624,000,000
Change in NCWC 166,000,000
EBIT 1,119,000,000
Tax Provision -110,000,000
Depreciation and Amortization 301,000,000
Capital Expenditure -194,000,000
Unlevered Free Cash Flow 1,392,000,000

This analysis is provided for informational purposes only and does not constitute financial or investing advice. For more information on the advantages and limitations of DCF analysis see background. This information is provided on an "as is" basis. No warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. By using this site you agree that under no circumstances shall Valuation Tools LLC be held liable for any loss or damage caused by information obtained from this website including any articles, data, videos, its social media accounts, or any other materials.